Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OnSight 3D Extremity System

K-Number: K160723 · 2016-08-30

Decision Date2016-08-30
Product CodeJAK
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

OnSight 3D Extremity System is a medical device manufactured by Carestream Health, Inc.. It received FDA 510(k) clearance on 2016-08-30 under approval number K160723. The device is classified under product code JAK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OnSight 3D Extremity System?

OnSight 3D Extremity System is a medical device that received FDA 510(k) clearance on 2016-08-30. It is manufactured by Carestream Health, Inc.. The 510(k) number is K160723.

When was OnSight 3D Extremity System approved by the FDA?

OnSight 3D Extremity System received FDA 510(k) clearance on 2016-08-30, under approval number K160723.

What company makes OnSight 3D Extremity System?

OnSight 3D Extremity System is manufactured by Carestream Health, Inc..

What is the FDA product code for OnSight 3D Extremity System?

The FDA product code for OnSight 3D Extremity System is JAK.

Related Clinical Trials

Other Devices by Carestream Health, Inc.

View all 23 devices →

Related Devices (Code: JAK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.